Equity Details
Price & Market Data
Price: $6.15
Daily Change: +$1.07 / 17.40%
Daily Range: $5.08 - $6.15
Market Cap: $383,068,540
Daily Volume: 200
Performance Metrics
1 Week: 10.04%
1 Month: 10.04%
3 Months: -8.06%
6 Months: -1.41%
1 Year: -1.41%
YTD: -1.58%
About (IPLTF)
Your daily market report for undefined (IPLTF). Price: 6.15, daily change: +$1.07 / 17.40%. Market cap: 383,068,540. Full performance analysis from YTD to 52-week.
Details
Implantica AG engages in the research and distribution of medical implants in Switzerland. The company's lead product candidate is RefluxStop, a passive CE-marked implant for prevention of gastroesophageal reflux disease. It focuses on two treatment areas, Gastrointestinal surgery and Urology. It is also involved in the development of eHealth platform, a digital health system to support its pipeline of smart medical implants designed for a safe and secure control and monitoring over the internet; e-InVivo, a sensor implants to monitor a multitude of health parameters and provide diagnostic information, as well as control treatment from inside the body; wireless energizing platform; and AppetiteControl, an implant to treat obesity by controlling appetite. In addition, the company develops UriControl, a hand pumped artificial urinary sphincter to treat urinary incontinence for men and women; and UriRestor, a remote-controlled device that enables spinal cord injury and multiple sclerosis patients to urinate on demand using the wireless platform. Further, it provides PotencyFlow for treatment of erectile dysfunction; StomaRestore for eliminating stoma bags; RectalRestore for treatment of fecal incontinence; and AneurysmControl for monitoring the expansion of the aneurysms. The company was founded in 2015 and is based in Vaduz, Liechtenstein.
